First Quadrant’s Impax Laboratories, Inc. IPXL Stock Holding History

First Quadrant’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-46,114	Closed	-$897K	–	901
2018 Q1	$897K	Buy	+46,114	New	+$905K	0.02%	412
2017 Q1	–	Sell	-30,600	Closed	-$405K	–	869
2016 Q4	$405K	Sell	30,600 -18,700	-38%	-$320K	0.01%	562
2016 Q3	$1.17M	Sell	49,300 -42,300	-46%	-$1.14M	0.02%	408
2016 Q2	$2.64M	Hold	91,600	–	–	0.06%	262
2016 Q1	$2.93M	Hold	91,600	–	–	0.06%	252
2015 Q4	$3.92M	Hold	91,600	–	–	0.09%	235
2015 Q3	$3.23M	Hold	91,600	–	–	0.07%	252
2015 Q2	$4.21M	Hold	91,600	–	–	0.09%	215
2015 Q1	$4.29M	Hold	91,600	–	–	0.09%	203
2014 Q4	$2.9M	Hold	91,600	–	–	0.06%	244
2014 Q3	$2.17M	Hold	91,600	–	–	0.05%	283
2014 Q2	$2.75M	Hold	91,600	–	–	0.06%	273
2014 Q1	$2.42M	Hold	91,600	–	–	0.05%	279
2013 Q4	$2.3M	Hold	91,600	–	–	0.05%	292
2013 Q3	$1.88M	Sell	91,600 -1,900	-2%	-$39.2K	0.05%	303
2013 Q2	$1.86M	Buy	+93,500	New	+$1.66M	0.05%	295

First Quadrant's IPXL Position: Q2 2018 in Review

First Quadrant sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 46,114 shares — an estimated $897K sold.

First Quadrant first reported a position in IPXL in Q2 2013 and held it in 16 quarters. The position peaked at $4.29M in Q1 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

First Quadrant reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
First Quadrant sold 46,114 Impax Laboratories, Inc. shares in Q2 2018, an estimated $897K.
First Quadrant first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 16 quarters.
First Quadrant's Impax Laboratories, Inc. position peaked at $4.29M in Q1 2015.
1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on First Quadrant's 13F filing for Q2 2018, filed 27 Jul 2018.